Deadline:  March 24, 2014

The McKnight Endowment Fund for Neuroscience supports innovative research designed to bring science closer to the day when diseases of the brain can be accurately diagnosed, prevented, and treated. To this end, the McKnight Memory and Cognitive Disorders Award assists scientists working to apply the knowledge achieved through basic research to human brain disorders that affect memory or cognition.

Use of Award Funds

We are interested in proposals that address memory or cognition under normal and pathological conditions. This includes proposals that address mechanisms of memory or cognition at the synaptic, cellular, or behavioral level in animals, including humans.We are particularly interested in proposals that incorporate fundamentally new approaches, as well as those that involve human experimentation. Collaborative and cross-disciplinary applications are encouraged.

Projects restricted to the creation of conventional mouse knockouts in candidate disease genes identified by association studies, or to broadly overexpress those genes, are discouraged. In addition, projects to perform genetic interaction screens on disease genes in model organisms (yeast, worm, fly, fish) will not be considered, unless the project includes substantive specific aims that investigate the disease relevance of any new genes so discovered in human or mammalian model systems.


Investigators who are United States citizens or lawful permanent residents conducting research at institutions within the United States are invited to apply. All PIs on the project must be U.S. citizens or have permanent resident status at the time of submission. Applicants must be in tenured or tenure-track faculty positions; research faculty in annually renewable positions are ineligible. Applicants may not be employees of the Howard Hughes Medical Institute or scientists within the intramural program of the National Institutes of Health. Applicants may not hold another McKnight Award that would overlap with the Memory and Cognitive Disorders Award. We are interested in geographic, gender, and racial diversity and we encourage women and minorities, as well as scientists from around the U.S., to apply. Funds may be used toward a variety of research activities, but not the recipient’s salary. The candidate’s other sources of funding will be considered when selecting awards.

Selection Process

For an application form, please visit our website at www.neuroscience.mcknight.org, or email or call the office of The McKnight Endowment Fund for Neuroscience (info@mcknight.org; 612-333-4220). The deadline for submission is March 24, 2014. In mid June, the selection committee will invite a small number of applicants to submit more detailed proposals, which will be due October 6, 2014. Funding begins February 1, 2015. Please email ONE PDF file and include the application form, the 2-page project description, and a 4-page NIH bio sketch to: neuro@mcknight.org (references may be outside the 2-page limit, but may be no more than two pages). Please do not include a budget. If you do not receive email confirmation of receipt of your LOI within 5 business days, please contact Eileen Maler at 612-333-4220 or emaler@mcknight.org.

The Endowment Fund will fund up to four awards, each providing $100,000 per year for three years.


Selection Committee

Wendy Suzuki, Ph.D. (Chair)

Robert Edwards, M.D. * Howard Eichenbaum, Ph.D. * Helen Mayberg, M.D.

 Robert Malenka, M.D., Ph.D., * Richard O’Brien, M.D., Ph.D. * Steve Petersen, Ph.D.

 Matthew Shapiro, Ph.D.


NE LB506 Cancer and Smoking Disease Research Grant

Internal Deadline:  Friday, January 31, 2014

The Nebraska Department of Health and Human Services (NE DHHS) has announced the Fiscal Year 2015 Cancer and Smoking Disease Research Grant competition. Funded by NE LB506, this program focuses on reducing cancer and smoking-related heart disease. Proposals relating directly to the prevention of cancer and smoking-related diseases – or the prevention or cessation of smoking in racial/ethnic minorities – will be given highest priority.

Link to NE DHHS information

2014 LB506 RFA

Innovative-Translational Cancer Research

Deadline:  Monday, February 3, 2014
Amount:  up to $10,000
One Application per accredited medical school and school of public health in the United States.  Contact UNMC Sponsored Programs to apply for this award.

The Mary Kay Foundation, a funding source for cancer research, is currently accepting applications for innovative grants for translational research in ovarian, uterine, breast, or cervical cancer.

The program will offer between ten to fifteen grants. The awards will be up to $100,000 each (combined direct and indirect costs). The grant period is for two years. Applications must be submitted by one Principal Investigator, selected by the Institution.  Only one grant application will be accepted from each accredited medical school and school of public health in the United States.

Grants are limited to the United States. Application guidelines and instructions are included in this announcement.